Dorsey Wright & Associates’s Compugen CGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding CGEN
AIM
NAMA
RSCM
BHC
TFCM
Dorsey Wright & Associates's CGEN Position: Q4 2020 in Review
Dorsey Wright & Associates sold out of Compugen (CGEN) in Q4 2020, closing a stake of 1,492 shares — an estimated $24K sold.
Dorsey Wright & Associates first reported a position in CGEN in Q4 2019 and held it in 4 quarters. The position peaked at $29K in Q2 2020. 101 funds tracked by Wall St. Rank hold CGEN as of Q4 2020.
- Dorsey Wright & Associates reported no remaining Compugen position as of Q4 2020 after selling out during the quarter.
- Dorsey Wright & Associates sold 1,492 Compugen shares in Q4 2020, an estimated $24K.
- Dorsey Wright & Associates first reported a position in Compugen in Q4 2019 and held it in 4 quarters.
- Dorsey Wright & Associates's Compugen position peaked at $29K in Q2 2020.
- 101 funds tracked by Wall St. Rank held Compugen as of Q4 2020.
Based on Dorsey Wright & Associates's 13F filing for Q4 2020, filed 28 Jan 2021.